Published in J Biomed Sci on September 17, 2015
Circulating markers of bone turnover. J Nephrol (2017) 0.75
Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin. Osteoporos Int (2017) 0.75
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature (1997) 7.10
Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A (2008) 4.77
Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab (2008) 2.84
Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis (2005) 2.40
Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab (2008) 2.30
Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis (2011) 1.63
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta (2008) 1.43
Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37
The connection between C-reactive protein and atherosclerosis. Ann Med (2008) 1.29
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.27
Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults. Obesity (Silver Spring) (2012) 1.01
Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial (2011) 0.99
Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2013) 0.94
Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem (2001) 0.94
Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant (2004) 0.91
Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes. Int J Endocrinol (2013) 0.91
Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am J Cardiol (2004) 0.90
Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease. J Ren Care (2011) 0.89
Osteocalcin: a novel vascular metabolic and osteoinductive factor? Arterioscler Thromb Vasc Biol (2011) 0.89
Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension. Kidney Blood Press Res (2010) 0.87
Relation of serum osteocalcin level to risk of coronary heart disease in Chinese adults. Am J Cardiol (2010) 0.85
Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes. Diabetes Metab (2011) 0.82
Elevated undercarboxylated and reduced carboxylated osteocalcin are associated with metabolic syndrome in middle age Asian females. Exp Clin Endocrinol Diabetes (2013) 0.80
Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome. Atherosclerosis (2014) 0.78